Gonçalves Ana C, Falcão Amílcar, Alves Gilberto, Lopes João A, Silva Luís R
CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.
CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal.
Pharmaceutics. 2022 Oct 24;14(11):2272. doi: 10.3390/pharmaceutics14112272.
Anthocyanins are among the best-known phenolic compounds and possess remarkable biological activities, including antioxidant, anti-inflammatory, anticancer, and antidiabetic effects. Despite their therapeutic benefits, they are not widely used as health-promoting agents due to their instability, low absorption, and, thus, low bioavailability and rapid metabolism in the human body. Recent research suggests that the application of nanotechnology could increase their solubility and/or bioavailability, and thus their biological potential. Therefore, in this review, we have provided, for the first time, a comprehensive overview of in vitro and in vivo studies on nanocarriers used as delivery systems of anthocyanins, and their aglycones, i.e., anthocyanidins alone or combined with conventional drugs in the treatment or management of chronic diseases.
花青素是最著名的酚类化合物之一,具有显著的生物活性,包括抗氧化、抗炎、抗癌和抗糖尿病作用。尽管它们具有治疗益处,但由于其不稳定性、低吸收率,以及因此导致的低生物利用度和在人体中的快速代谢,它们并未被广泛用作促进健康的药物。最近的研究表明,纳米技术的应用可以提高它们的溶解度和/或生物利用度,从而提高它们的生物潜力。因此,在本综述中,我们首次全面概述了关于用作花青素及其苷元(即仅花青素或与传统药物联合使用的花青素)递送系统的纳米载体在治疗或管理慢性疾病方面的体外和体内研究。